Muscle-Invasive Bladder Carcinoma
Oncology
1
Pipeline Programs
3
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
CG OncologyCG0070
GenomicsC2i Test
Clinical Trials (2)
Total enrollment: 3 patients across 2 trials
Study of CG0070 Combined With Nivolumab in Cisplatin Ineligible Patients With MIBC
Start: Oct 2020Est. completion: Jul 2024
Phase 1Completed
Clinical Performance Evaluation of the C2i-Test
Start: Feb 2022Est. completion: Jul 20223 patients
N/ATerminated
Related Jobs in Oncology
Cell Therapy Account Manager（北陸）
Gilead Sciences
Japan - Tokyo
Just now
Leo Cancer Care: Senior In-House Counsel/General Counsel
Leo Cancer Care
Middleton, Wisconsin
6h ago
Summer Intern - Computational Chemistry & Artificial Intelligence
Arvinas
Remote
8h ago
Executive Medical Director, Oncology Early Development
AbbVie
Florham Park, NJ
8h ago
Executive Medical Director, Oncology Early Development
AbbVie
South San Francisco, CA
8h ago
Executive Medical Director, Oncology Early Development
AbbVie
North Chicago, IL
8h ago
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
3 companies competing in this space